Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Venu Holding Corporation Reports Its 2024 Annual Results
-
FRP Holdings Announces Investor Day, Conference Participation and its New Investor Website and Presentation
-
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
-
First Trust Enhanced Equity Income Fund Issues Notice Regarding March 2025 Distribution
-
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
-
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
-
Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025
-
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
-
IDEX Biometrics ASA - Information about the second exercise period for warrants (Warrants B) issued in connection with the Private Placement and Subsequent Offering
-
Kingsway Financial Services Inc. Appoints Adam J. Patinkin and Joshua S. Horowitz to Its Board of Directors
-
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
-
ClearOne, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
-
NYU Langone Health Names Alec C. Kimmelman, MD, PhD as Next CEO and Dean
-
Wendel completes the acquisition of a controlling stake in Monroe Capital LLC, a transformational transaction in line with its strategic roadmap
-
Wintrust Financial Corporation Announces First Quarter 2025 Earnings Release Schedule
-
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
-
Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements
-
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
-
Open Lending Reports Fourth Quarter and Full Year 2024 Financial Results
-
Birchtech Reports Fourth Quarter 2024 Financial Results
-
Agree Realty Announces $625 Million Commercial Paper Program
-
Huntington Bancshares Incorporated Declares Cash Dividend On Its Series I Preferred Stock
-
Local Bounti Announces Full Year 2024 Financial Results
-
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Velo3D Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
-
ICF Announces Timing of First Quarter 2025 Earnings Release and Conference Call
-
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
Spruce Power Reports Fourth Quarter and Full-Year 2024 Results
-
ESS Tech, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
-
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
-
PepGen Announces Appointment of Two New Directors to its Board
-
VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update
-
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
-
Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024
-
AppLovin to Announce First Quarter 2025 Results
-
Circle Pharma to Present at the Upcoming Investor Conferences
-
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Equity Stock Transfer teams up with Newsmax Inc. for historic IPO opening on New York Stock Exchange’s main board
-
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
-
Applied Digital Sets Fiscal Third Quarter 2025 Conference Call for Monday, April 14, 2025, at 5:00 p.m. Eastern Time
-
Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results
-
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
-
Progress Announces First Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
-
Revolution Medicines to Participate in April 2025 Investor Conferences
-
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results


